Swiss All Share Index
18.370,23
PKT
+147,90
PKT
+0,81
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.02.18 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 09.02.18 | Zurich Insurance Halten | DZ BANK | |
| 09.02.18 | Swiss Re buy | Deutsche Bank AG | |
| 09.02.18 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 09.02.18 | Zurich Insurance Equal weight | Barclays Capital | |
| 09.02.18 | ABB (Asea Brown Boveri) buy | S&P Capital IQ | |
| 09.02.18 | Zurich Insurance Hold | Kepler Cheuvreux | |
| 09.02.18 | Novartis buy | Kepler Cheuvreux | |
| 09.02.18 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 09.02.18 | Zurich Insurance Hold | S&P Capital IQ | |
| 08.02.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 08.02.18 | Zurich Insurance Outperform | RBC Capital Markets | |
| 08.02.18 | Zurich Insurance Neutral | UBS AG | |
| 08.02.18 | Swiss Re Sell | UBS AG | |
| 08.02.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 08.02.18 | Zurich Insurance Hold | Kepler Cheuvreux | |
| 08.02.18 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 08.02.18 | UBS overweight | JP Morgan Chase & Co. | |
| 08.02.18 | Zurich Insurance Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.02.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.02.18 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 07.02.18 | Zurich Insurance Conviction Buy | Goldman Sachs Group Inc. | |
| 07.02.18 | Nestlé buy | Goldman Sachs Group Inc. | |
| 07.02.18 | UBS buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.02.18 | Roche Neutral | UBS AG | |
| 06.02.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.02.18 | Roche overweight | JP Morgan Chase & Co. | |
| 06.02.18 | Givaudan Neutral | UBS AG | |
| 05.02.18 | Roche overweight | Barclays Capital | |
| 05.02.18 | Givaudan Neutral | UBS AG | |
| 05.02.18 | Roche Hold | Deutsche Bank AG | |
| 02.02.18 | Roche overweight | JP Morgan Chase & Co. | |
| 02.02.18 | Roche kaufen | DZ BANK | |
| 02.02.18 | Roche Outperform | Bernstein Research | |
| 02.02.18 | Swiss Re buy | Deutsche Bank AG | |
| 01.02.18 | Zurich Insurance Equal weight | Barclays Capital | |
| 01.02.18 | Swiss Re overweight | Barclays Capital | |
| 01.02.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 31.01.18 | Nestlé Neutral | BNP PARIBAS | |
| 30.01.18 | Givaudan Sell | Citigroup Corp. |